Research Analysts’ upgrades for Friday, May 24th:

ABIOMED (NASDAQ:ABMD) was upgraded by analysts at BidaskClub from a strong sell rating to a sell rating.

ArQule (NASDAQ:ARQL) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

Cracker Barrel Old Country Store (NASDAQ:CBRL) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

Cyberark Software (NASDAQ:CYBR) was upgraded by analysts at BidaskClub from a buy rating to a strong-buy rating.

Five9 (NASDAQ:FIVN) was upgraded by analysts at BidaskClub from a buy rating to a strong-buy rating.

Grupo Financiero Galicia (NASDAQ:GGAL) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

Iovance Biotherapeutics (NASDAQ:IOVA) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

Kimball Electronics (NASDAQ:KE) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.

Kodiak Sciences (NYSE:KOD) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $11.00 target price on the stock. According to Zacks, “Kodiak Sciences Inc. operates as a clinical stage biopharmaceutical company. It specializes in novel therapeutics to treat chronic and retinal diseases. The company’s product candidates consists of KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and Uveitis, KSI-201 for treatment resistant wet AMD and KSI-401 for dry AMD which are in clinical stage. Kodiak Sciences Inc. is based in CA, United States. “

Lakeland Bancorp (NASDAQ:LBAI) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $18.00 target price on the stock. According to Zacks, “LAKELAND BANCORP INC. is a bank holding company engaged in general banking business. “

Mitchells & Butlers (LON:MAB) was upgraded by analysts at Liberum Capital to a buy rating. They currently have GBX 340 ($4.44) target price on the stock, up from their previous target price of GBX 270 ($3.53).

Mamamancini’s (OTCMKTS:MMMB) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “MamaMancini’s Holding’s, Inc. is involved in manufacturing & distributing of food products primarily in the United States. It offers beef meatballs with sauce, turkey meatballs with sauce, chicken meatballs with sauce, pork meatballs with sauce and other similar Italian products. The company sells its products to supermarket and mass market retailers. MamaMancini’s Holding’s, Inc. is based in East Rutherford, New Jersey. “

Mirati Therapeutics (NASDAQ:MRTX) was upgraded by analysts at BidaskClub from a buy rating to a strong-buy rating.

Maxim Integrated Products (NASDAQ:MXIM) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.

Nektar Therapeutics (NASDAQ:NKTR) was upgraded by analysts at BidaskClub from a strong sell rating to a sell rating.

O’Reilly Automotive (NASDAQ:ORLY) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.

pdvWireless (NASDAQ:PDVW) was upgraded by analysts at BidaskClub from a buy rating to a strong-buy rating.

Royal Mail (LON:RMG) was upgraded by analysts at Liberum Capital to a hold rating. They currently have GBX 185 ($2.42) target price on the stock, down from their previous target price of GBX 240 ($3.14).

Rhythm Pharmaceuticals (NASDAQ:RYTM) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

Serco Group (LON:SRP) was upgraded by analysts at Liberum Capital to a buy rating. They currently have GBX 150 ($1.96) price target on the stock, up from their previous price target of GBX 130 ($1.70).

Telenav (NASDAQ:TNAV) was upgraded by analysts at BidaskClub from a buy rating to a strong-buy rating.

Vodafone Group (LON:VOD) was upgraded by analysts at HSBC Holdings plc to a buy rating.

Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at BidaskClub from a sell rating to a hold rating.

Wendys (NASDAQ:WEN) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

Receive News & Ratings for ABIOMED Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ABIOMED Inc and related companies with MarketBeat.com's FREE daily email newsletter.